MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Wednesday, June 22, 2016

12:00pm-1:30pm
Evaluation of the surface based measures to discriminate progressive supranuclear palsy from corticobasal syndrome

N. Upadhyay, A. Suppa, M.C. Piattella, F.D. Stasio, C. Colonnese, C. Colosimo, A. Berardelli, P. Pantano (Rome, Italy)

Neuroimaging (non-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Evidence of striatal dopaminergic dysfunction Sydenham’s chorea in remission with (99m)Tc-TRODAT-1 SPECT

R. Maciel, D. Maia, C.F. de Lima, F. Cardoso (Belo Horizonte, Brazil)

Choreas (non-Huntington's disease)  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Excessive daytime sleepiness is mediated by loss of caudate dopaminergic function in Parkinson’s disease

T. Yousaf, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Executive function and verbal fluency in patients with Parkinson’s disease

A.F. Barbosa, M.C. Voos, C.O. Souza, J. Chen, H.F. Chien, D.V. Francato, E.R. Barbosa, L.L. Mansur (São Paulo, Brazil)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Exploring structural covariance networks of gray matter in Parkinson’s disease

L.J. de Schipper, J. van der Grond, J. Marinus, J.J. van Hilten (Leiden, Netherlands)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Exploring the brainstem functions in cervical dystonia

P. Tocco, M.C. Tozzi, S. Monaco, L. Bertolasi (Verona, Italy)

Neurophysiology (non-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Extensive bilateral basal ganglia and cerebellar calcification in Fahr’s syndrome after thyroidectomy

T. Uyar, K. Paksoy, C. Çokluk (Rize, Turkey)

Neuroimaging (non-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases

H. Schmitz-Peiffer, K. Linse, W. Rüger, M. Joos, M. Löhle, A. Storch, A. Hermann (Dresden, Germany)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Facial expressivity in Parkinson’s disease (PD) via an examination of smiling behavior: Preliminary findings

D.L. McCabe, A.D. Bono, R.J. Stafford, A.I. Dumer, K.A. Scorpio, J.L. Spielman, R. Bind, L.O. Ramig, J.C. Borod (New York, NY, USA)

Parkinson's disease: Psychiatric manifestations  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Factors related to psychotic symptoms in patients with Parkinson’s disease

B. Tserensodnom (Ulaanbaatar, Mongolia)

Parkinson's disease: Psychiatric manifestations  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 54
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley